PhD in Fundamental Immunology - Cancer Immunology in Toronto Canada | University of Toronto

The Department of Immunology provides graduate programs for both Master of Science and Doctor of Philosophy degrees, covering diverse immunological fields. These areas encompass lymphocyte development mechanisms, T-cell/B-cell receptor studies, cellular interactions, cytokine systems, antigen processing, lymphocyte signaling, genetic recombination, immune tolerance, programmed cell death, genetically modified models, vaccine development, autoimmune disorders, HIV research, metabolic diseases, and organ transplantation.
This department serves as a collaborative hub for researchers across the University of Toronto, offering interdisciplinary immunological training. Faculty and students work across multiple locations including the Medical Sciences Building, Ontario Cancer Institute, and various hospital research centers. The PhD program equips students with advanced research capabilities through rigorous coursework in contemporary immunology and the development of publishable research projects.
Cancer originates from normal cells that undergo uncontrolled growth due to genetic abnormalities. Immune system components can transform into cancerous forms like leukemias and lymphomas. The immune system actively suppresses cancer development, though some malignant cells evade detection by maintaining normal surface markers despite internal changes, allowing unchecked proliferation.
Researchers are developing innovative cancer treatments, particularly immunotherapies that harness the body's immune defenses against tumors. While many cancer cells appear normal, they often express atypical antigens - either developmentally inappropriate or tissue-specific markers. Current therapeutic approaches focus on identifying these unique cancer markers and training the immune system to target cells displaying them.